SPRB logo

Spruce Biosciences, Inc. (SPRB)

Profile

Full Name

Spruce Biosciences, Inc.

Ticker

NASDAQ: SPRB

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 9, 2020

Indexes

Not included

Website

https://sprucebio.com

Employees

20

Key Details

Price

$135.17(4.04%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$4.91M(-51.32% YoY)

Annual EPS

-$96.39(-7646.89% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $135.17
    SPRB price is $135.17

    30-Day Relative Volume

    0.94
    SPRB 30-day relative volume is 0.94

    Price Performance

    Price 1-Day Change

    +4.04%
    SPRB price is up +4.04% today

    Price YTD Change

    -94.28%
    SPRB price is down -94.28% since January 1st

    Price 1-Year Change

    -95.89%
    SPRB price is down -95.89% year-on-year

    Price 3-Year Change

    -97.75%
    SPRB price is down -97.75% over the past 3 years

    Price Range

    Price All-Time High

    $200250.00
    SPRB price is currently -99.93% below its historical high of $200250.00

    Price 3-Year Low

    $7.00
    SPRB price is currently +1831.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $76.11M
    SPRB market cap is $76.11 million

    Market Cap 3-Year Change

    -95.97%
    SPRB market cap is down -95.97% over the past 3 years

    Market Cap All-Time High

    $56.44B
    SPRB market cap is currently -99.87% below its historical high of $56.44 billion

    Market Cap Sector Percentile

    35.98%
    SPRB market cap is higher than 35.98% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +2.25%
    SPRB shares outstanding is up +2.25% year-on-year

    Shares Outstanding 3-Year Change

    +79.27%
    SPRB shares outstanding is up +79.27% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.76
    SPRB beta is 1.76

    200-day SMA

    $866.54
    SPRB price is currently -84.40% below its 200-day simple moving average

    50-day SMA

    $49.85
    SPRB price is currently +171.14% above its 50-day simple moving average

    14-Day RSI

    55.90
    SPRB 14-day relative strength index is 55.90

    Volume

    0.94
    SPRB 30-day relative volume is 0.94

    ATR

    $22.73
    SPRB average true range is $22.73

    10-day Historical Volatility

    124.77%
    SPRB 10-day historical volatility is 124.77%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $4.91M
    SPRB annual revenue is $4.91 million

    Revenue Analysts Estimate

    -
    SPRB annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    -51.32%
    SPRB annual revenue is down -51.32% year-on-year

    Revenue Sector Percentile

    43.42%
    SPRB annual revenue is higher than 43.42% of companies in Healthcare sector

    EPS

    EPS

    -$96.39
    SPRB annual earnings per share is -$96.39

    EPS Analysts Estimate

    -$2.83
    SPRB annual earnings per share is currently -3306.17% lower than the consensus analysts' forecast

    EPS 1-Year Change

    -7646.89%
    SPRB annual earnings per share is down -7646.89% year-on-year

    EPS Sector Percentile

    2.96%
    SPRB annual earnings per share is higher than 2.96% of companies in Healthcare sector

    Profit

    Gross Profit

    $4.87M
    SPRB annual gross profit is $4.87 million

    Gross Margin

    99.06%
    SPRB annual gross profit margin is 99.06%

    Operating Profit

    -$56.15M
    SPRB annual operating income is -$56.15 million

    Operating Margin

    -1143.37%
    SPRB annual operating profit margin is -1143.37%

    Net Income

    -$53.04M
    SPRB annual net profit is -$53.04 million

    Net Margin

    -1079.94%
    SPRB annual net profit margin is -1079.94%

    Expenses

    Total Expenses

    $61.06M
    SPRB annual total expenses is $61.06 million

    Operating Expenses

    $61.06M
    SPRB annual total operating expenses is $61.06 million

    Cost Of Goods Sold

    $46.00K
    SPRB annual cost of goods sold is $46.00 thousand

    Selling, General & Administrative Expenses

    $14.64M
    SPRB annual SG&A is $14.64 million

    Depreciation & Amortization

    $46.00K
    SPRB annual D&A is $46.00 thousand

    Interest Expense

    $307.00K
    SPRB annual interest expense is $307.00 thousand

    Income Tax

    $0.00
    SPRB annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$52.73M
    SPRB annual earnings before interest & taxes is -$52.73 million

    EBITDA

    -$52.68M
    SPRB annual EBITDA is -$52.68 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $45.21M
    SPRB annual total assets is $45.21 million

    Non Current Assets

    $1.00M
    SPRB annual long term assets is $1.00 million

    Current Assets

    $44.21M
    SPRB annual total current assets is $44.21 million

    Cash and Cash Equivalents

    $38.75M
    SPRB annual cash & cash equivalents is $38.75 million

    Accounts Receivable

    -
    SPRB annual accounts receivable value is unknown

    Inventory

    $0.00
    SPRB annual inventory is $0.00

    Liabilities

    Total Liabilities

    $16.39M
    SPRB annual total liabilities is $16.39 million

    Long Term Liabilities

    $1.14M
    SPRB annual total long term liabilities is $1.14 million

    Current Liabilities

    $15.25M
    SPRB annual current liabilities is $15.25 million

    Accounts Payable

    $1.29M
    SPRB annual accounts payable is $1.29 million

    Debt

    Total Debt

    $2.77M
    SPRB annual total debt is $2.77 million

    Total Debt 1-Year Change

    -40.01%
    SPRB annual total debt is down -40.01% year-on-year

    Long Term Debt

    $860.00K
    SPRB annual long term debt is $860.00 thousand

    Short Term Debt

    $1.91M
    SPRB annual short term debt is $1.91 million

    Equity & Capital

    Shareholders Equity

    $28.82M
    SPRB annual stockholders equity is $28.82 million

    Book Value

    $28.82M
    SPRB annual book value is $28.82 million

    Retained Earnings

    -$250.27M
    SPRB annual retained earnings is -$250.27 million

    Working Capital

    $28.96M
    SPRB annual working capital is $28.96 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$55.96M
    SPRB annual cash from operations is -$55.96 million

    Cash From Operations 1-Year Change

    -68.19%
    SPRB annual cash from operations is down -68.19% year-on-year

    Cash From Investing

    $0.00
    SPRB annual cash from investing is $0.00

    Cash From Investing 1-Year Change

    -100%
    SPRB annual cash from investing is down -100% year-on-year

    Cash From Financing

    -$1.62M
    SPRB annual cash from financing is -$1.62 million

    Cash From Financing 1-Year Change

    -103.3%
    SPRB annual cash from financing is down -103.3% year-on-year

    CAPEX

    CAPEX

    $0.00
    SPRB annual capital expenditures is $0.00

    CAPEX 1-Year Change

    -100%
    SPRB annual capital expenditures is down -100% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$55.96M
    SPRB annual free cash flow is -$55.96 million

    Free Cash Flow 1-Year Change

    -68.15%
    SPRB annual free cash flow is down -68.15% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    99.06%
    SPRB annual gross profit margin is 99.06%

    Operating Margin

    -1143.37%
    SPRB annual operating profit margin is -1143.37%

    Net Margin

    -1079.94%
    SPRB annual net profit margin is -1079.94%

    ROA & ROE

    ROA

    -71.12%
    SPRB annual return on assets is -71.12%

    ROE

    -100.70%
    SPRB annual return on equity is -100.70%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    SPRB price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    SPRB price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    5.77
    SPRB price to book ratio is 5.77

    PB Ratio Sector Percentile

    79.71%
    SPRB price to book ratio is higher than 79.71% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    58.59
    SPRB price to sales ratio is 58.59

    PS Ratio Sector Percentile

    86.82%
    SPRB price to sales ratio is higher than 86.82% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $61.55M
    SPRB enterprise value is $61.55 million

    Enterprise Value Sector Percentile

    38.47%
    SPRB enterprise value is higher than 38.47% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.22
    SPRB EV/EBITDA is -1.22

    EV/EBITDA Sector Percentile

    46.87%
    SPRB EV/EBITDA is higher than 46.87% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    2.90
    SPRB annual current ratio is 2.90

    Quick Ratio

    2.90
    SPRB annual quick ratio is 2.90

    Leverage

    Debt To Equity

    0.10
    SPRB annual debt to equity ratio is 0.10

    Interest Coverage Ratio

    -171.76
    SPRB annual interest coverage ratio is -171.76

    Risk & Stability

    F-Score

    -
    SPRB piotroski f-score value is unknown

    Altman Z-Score

    -7.94
    SPRB altman z-score is -7.94

    Analyst ratings

    Recent major analysts updates

    Apr 16, 25 RBC Capital
    Sector Perform
    Dec 16, 24 HC Wainwright & Co.
    Neutral
    Dec 12, 24 Guggenheim
    Neutral
    Dec 11, 24 RBC Capital
    Sector Perform
    Dec 11, 24 Oppenheimer
    Perform
    Dec 11, 24 JMP Securities
    Market Perform
    Nov 12, 24 RBC Capital
    Sector Perform
    Aug 19, 24 HC Wainwright & Co.
    Neutral
    Aug 13, 24 RBC Capital
    Sector Perform
    Jun 13, 24 Oppenheimer
    Outperform

    Institutional Ownership

    Screeners with SPRB included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Stocks below SMA 200
    Stocks recommended to hold
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    Stocks above analysts price target
    • What is the ticker symbol for Spruce Biosciences, Inc.?
    • Does Spruce Biosciences, Inc. pay dividends?
    • What sector is Spruce Biosciences, Inc. in?
    • What industry is Spruce Biosciences, Inc. in?
    • What country is Spruce Biosciences, Inc. based in?
    • When did Spruce Biosciences, Inc. go public?
    • Is Spruce Biosciences, Inc. in the S&P 500?
    • Is Spruce Biosciences, Inc. in the NASDAQ 100?
    • Is Spruce Biosciences, Inc. in the Dow Jones?
    • When was Spruce Biosciences, Inc.'s last earnings report?
    • When does Spruce Biosciences, Inc. report earnings?

    What is the ticker symbol for Spruce Biosciences, Inc.?

    The ticker symbol for Spruce Biosciences, Inc. is NASDAQ:SPRB

    Does Spruce Biosciences, Inc. pay dividends?

    No, Spruce Biosciences, Inc. does not pay dividends

    What sector is Spruce Biosciences, Inc. in?

    Spruce Biosciences, Inc. is in the Healthcare sector

    What industry is Spruce Biosciences, Inc. in?

    Spruce Biosciences, Inc. is in the Biotechnology industry

    What country is Spruce Biosciences, Inc. based in?

    Spruce Biosciences, Inc. is headquartered in United States

    When did Spruce Biosciences, Inc. go public?

    Spruce Biosciences, Inc.'s initial public offering (IPO) was on October 9, 2020

    Is Spruce Biosciences, Inc. in the S&P 500?

    No, Spruce Biosciences, Inc. is not included in the S&P 500 index

    Is Spruce Biosciences, Inc. in the NASDAQ 100?

    No, Spruce Biosciences, Inc. is not included in the NASDAQ 100 index

    Is Spruce Biosciences, Inc. in the Dow Jones?

    No, Spruce Biosciences, Inc. is not included in the Dow Jones index

    When was Spruce Biosciences, Inc.'s last earnings report?

    Spruce Biosciences, Inc.'s most recent earnings report was on November 14, 2022

    When does Spruce Biosciences, Inc. report earnings?

    The date for Spruce Biosciences, Inc.'s next earnings report has not been announced yet
    On this page